Carregant...
Incidence of Infusion Reactions to Anti-Neoplastic Agents in Early Phase Clinical Trials: The MD Anderson Cancer Center Experience
BACKGROUND: Infusion reactions (IRs) to anti-neoplastic agents require prompt recognition and immediate treatment to avert significant complications. METHODS: We conducted a retrospective review of the medical records of consecutive patients who received anti-neoplastic therapy in the outpatient tre...
Guardat en:
| Publicat a: | Invest New Drugs |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5896759/ https://ncbi.nlm.nih.gov/pubmed/27687047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-016-0395-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|